相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。1057PDFINAL RESULTS FROM A CANCER RESEARCH UK FIRST IN MAN PHASE I TRIAL OF IMA950 (A NOVEL MULTI PEPTIDE VACCINE) PLUS GM-CSF IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
S. Halford et al.
ANNALS OF ONCOLOGY (2017)
Ipilimumab and Bevacizumab in Glioblastoma
T. Carter et al.
CLINICAL ONCOLOGY (2016)
Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model
Mitsuto Hanihara et al.
JOURNAL OF NEUROSURGERY (2016)
Glioblastoma vaccine therapy disappointment in Phase III trial
Hemi Malkki
Nature Reviews Neurology (2016)
Increased proportion of FoxP3+regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
Elias J. Sayour et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression
Yu Shi et al.
CELL STEM CELL (2015)
The Evolution of T-cell Therapies for Solid Malignancies
Kristen Fousek et al.
CLINICAL CANCER RESEARCH (2015)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA
D. Saha et al.
DRUGS OF THE FUTURE (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pseudoprogression and Immune-Related Response in Solid Tumors
Victoria L. Chiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aleksanteri Aspelund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Leonel Ampie et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
Ichiyo Shibahara et al.
MOLECULAR CANCER (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
Powell Perng et al.
FRONTIERS IN ONCOLOGY (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro
Christian Pieper et al.
BRAIN RESEARCH (2014)
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Shannon L. Maude et al.
CANCER JOURNAL (2014)
Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells
Xiao-Jun Xu et al.
CANCER LETTERS (2014)
Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
Smita K. Nair et al.
CLINICAL CANCER RESEARCH (2014)
Phase II Trial of the Anti-CD19 Bispecific T Cell-Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
Max S. Topp et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
Andrea Gras Navarro et al.
JOURNAL OF IMMUNOLOGY (2014)
Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma
Glenda Maria Beaman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
Frederick F. Lang et al.
NEURO-ONCOLOGY (2014)
EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
Hongsheng Miao et al.
PLOS ONE (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
DCVax®-L-Developed by Northwest Biotherapeutics
Stavros Polyzoidis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Jianfang Ning et al.
FRONTIERS IN MICROBIOLOGY (2014)
Establishment of Tumor-Associated Immunity Requires Interaction of Heat Shock Proteins with CD91
Yu Jerry Zhou et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
Andrea Schuessler et al.
FRONTIERS IN ONCOLOGY (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Courtney A. Crane et al.
CLINICAL CANCER RESEARCH (2013)
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
Jon D. Laman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination
Erik H. J. G. Aarntzen et al.
ONCOIMMUNOLOGY (2013)
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
Xuguang Tai et al.
BLOOD (2012)
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till et al.
BLOOD (2012)
Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
Agata Juszczak et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Consensus on the role of human cytomegalovirus in glioblastoma
Kristine Dziurzynski et al.
NEURO-ONCOLOGY (2012)
Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I
Trisha R. Sippel et al.
CLINICAL CANCER RESEARCH (2011)
Oncolytic poliovirus against malignant glioma
Christian Goetz et al.
FUTURE VIROLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Imaging of cellular therapies
M. Srinivas et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
S. J. O'Day et al.
ANNALS OF ONCOLOGY (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
Allen Waziri
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Heat Shock Proteins: Cell Protection through Protein Triage
David Lanneau et al.
THESCIENTIFICWORLDJOURNAL (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Oliver M. Grauer et al.
BRAIN PATHOLOGY (2009)
Physiology and Therapeutics of Vascular Endothelial Growth Factor in Tumor Immunosuppression
Benjamin Johnson et al.
CURRENT MOLECULAR MEDICINE (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Toward Effective Immunotherapy for the Treatment of Malignant Brain Tumors
Duane A. Mitchell et al.
NEUROTHERAPEUTICS (2009)
FDA Drug Approval Summary: Bevacizumab (Avastin (R)) as Treatment of Recurrent Glioblastoma Multiforme
Martin H. Cohen et al.
ONCOLOGIST (2009)
Oncolytic measles virus strains in the treatment of gliomas
Cory Allen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas
Rae Myers et al.
HUMAN GENE THERAPY (2008)
Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
Elena Y. Dobrikova et al.
MOLECULAR THERAPY (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
Duane A. Mitchell et al.
NEURO-ONCOLOGY (2008)
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
Benjamin F. Johnson et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Dendritic cells and macrophages are productively infected by poliovirus
R Wahid et al.
JOURNAL OF VIROLOGY (2005)
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
M de la Rosa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Cutting edge: CD91-independent cross-presentation of GRP94(gp96)-associated peptides
B Berwin et al.
JOURNAL OF IMMUNOLOGY (2002)
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas
E Galanis et al.
HUMAN GENE THERAPY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Expression and functional activity of heat shock proteins in human glioblastoma multiforme
M Hermisson et al.
NEUROLOGY (2000)
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
AB Heimberger et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Poliovirus 2A protease induces apoptotic cell death
D Goldstaub et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
